What is Cue?

Cue is a connected, molecular diagnostic system

The Cue Health Monitoring System is a fast, compact, highly portable testing platform with no compromise in performance or accuracy. It uses molecular diagnostic technology to deliver reliable results in about 20 minutes.

Who we work with

Cue is partnering with leading organizations such as BARDA, Henry Schein, Johnson & Johnson, Mayo Clinic, and the National Basketball Association to further our science and protect human health.

Newsroom

View all press

Cue Receives CE Mark for Its Molecular Point-of-Care COVID-19 Test

Read more

Cue Health’s Connected Point-of-Care Covid-19 Test Demonstrates 97.8% Agreement When Compared to Central Lab PCR…

Read more

Cue’s Molecular, Point-of-Care COVID-19 Tests Now Available in 10 States Under Health and Human Services and…

Read more

Cue COVID-19 Test Highlighted by Assistant Secretary for Health, Admiral Brett Giroir, M.D. in HHS Telebriefing

Read more

Cue’s Molecular, Point-of-Care COVID-19 Tests Deployed to Five States in HHS and DOD Pilot Program

Read more

Cue’s CEO Ayub Khattak joins Lisa Ling on Season 2 of Johnson & Johnson’s COVID-19 Series: The Road to a Vaccine

Read more

Applications

One system, any industry

Accessible, accurate, scalable diagnostic testing for any industry, including healthcare, government, and education.

Who we are

Meet the team at Cue

We’re on a mission to transform how we detect disease and protect human health.

Made in the USA

Designed, engineered, manufactured, and tested in San Diego

Proudly headquartered in San Diego, Cue’s state-of-the-art space includes lab, office, and production facilities.